Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer
Recruiting
18-99 years
Male
Phase
N/A
100 participants needed
1 Location
Brief description of study
This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Prostate Cancer,Cancer
-
Age: Between 18 Years - 99 Years
-
Gender: Male
Males, 18 years of age, Recently diagnosed with prostate cancer
Updated on
01 Aug 2024.
Study ID: 833499
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
